APRE
Aprea Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.76
+1.32%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-5.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 17, 2026 | BIZZARI JEAN-PIERRE · director | A-Award | 3,135 | $0.00 |
| Jun 17, 2026 | Duey Marc · director | A-Award | 3,135 | $0.00 |
| Jun 17, 2026 | Duey Marc · director | A-Award | 12,555 | $0.73 |
| Jun 17, 2026 | Pamukcu Rifat · director | A-Award | 3,135 | $0.00 |
| Jun 17, 2026 | Pamukcu Rifat · director | A-Award | 12,555 | $0.73 |
| Jun 17, 2026 | Seizinger Bernd R. · director | A-Award | 3,135 | $0.00 |
| Jun 17, 2026 | Seizinger Bernd R. · director | A-Award | 12,555 | $0.73 |
| Jun 17, 2026 | Grissinger Michael · director | A-Award | 3,135 | $0.00 |
| Jun 17, 2026 | Peters Richard · director | A-Award | 3,135 | $0.00 |
| Jun 17, 2026 | Gruia Gabriela · director | A-Award | 12,555 | $0.73 |
| Jun 17, 2026 | Gruia Gabriela · director | A-Award | 3,135 | $0.00 |
| Jun 17, 2026 | Grissinger Michael · director | A-Award | 12,555 | $0.73 |
| Jun 17, 2026 | Peters Richard · director | A-Award | 12,555 | $0.73 |
| Jun 17, 2026 | HENNEMAN JOHN B III · director | A-Award | 3,135 | $0.00 |
| Jun 17, 2026 | HENNEMAN JOHN B III · director | A-Award | 12,555 | $0.73 |
| Jun 17, 2026 | BIZZARI JEAN-PIERRE · director | A-Award | 12,555 | $0.73 |
| Mar 16, 2026 | Hamill John P. · officer: SrVP/CFO/Prin Fin & Acct Ofcr | A-Award | 40,380 | $0.77 |
| Mar 16, 2026 | Gilad Oren · director, officer: President/CEO | A-Award | 80,700 | $0.77 |
| Mar 16, 2026 | Gilad Oren · director, officer: President/CEO | A-Award | 20,175 | $0.00 |
| Mar 16, 2026 | Hamill John P. · officer: SrVP/CFO/Prin Fin & Acct Ofcr | A-Award | 10,095 | $0.00 |
| Feb 2, 2026 | Hamill John P. · officer: SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | 5,700 | $0.89 |
| Feb 2, 2026 | Gilad Oren · director, officer: President/CEO | Purchase | 28,100 | $0.89 |
| Dec 11, 2025 | Gilad Oren · director, officer: President/CEO | Purchase | 21,459 | $0.00 |
| Dec 11, 2025 | Duey Marc · director | Purchase | 21,459 | $1.17 |
| Dec 11, 2025 | Hamill John P. · officer: SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | 5,000 | $1.17 |
| Jun 9, 2025 | Grissinger Michael · director | A-Award | 4,185 | $1.81 |
| Jun 9, 2025 | Pamukcu Rifat · director | A-Award | 1,045 | $0.00 |
| Jun 9, 2025 | Pamukcu Rifat · director | A-Award | 4,185 | $1.81 |
| Jun 9, 2025 | HENNEMAN JOHN B III · director | A-Award | 1,045 | $0.00 |
| Jun 9, 2025 | HENNEMAN JOHN B III · director | A-Award | 4,185 | $1.81 |
Institutional positioning
13F filings over the trailing two quarters
New 15Increased 9Reduced 10Sold out 2
| Filer | Action | Shares | Filed |
|---|---|---|---|
| AIGH CAPITAL MANAGEMENT LLC | Increased | 1,015,541 | Apr 30, 2026 |
| AIGH Capital Management LLC | Unchanged | 1,015,541 | Aug 7, 2026 |
| VESTAL POINT CAPITAL, LP | New Position | 350,000 | May 15, 2026 |
| Vestal Point Capital, LP | Unchanged | 350,000 | Aug 14, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | Unchanged | 270,000 | May 15, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | Unchanged | 270,000 | Aug 14, 2026 |
| Nantahala Capital Management, LLC | Unchanged | 205,760 | Aug 19, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | Unchanged | 205,760 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 119,131 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 105,800 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 74,869 | Aug 12, 2026 |
| SCIENTECH RESEARCH LLC | New Position | 60,281 | May 15, 2026 |
| CITADEL ADVISORS LLC | New Position | 58,600 | Sep 2, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | Increased | 45,211 | Aug 13, 2026 |
| DIADEMA PARTNERS LP | New Position | 44,907 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 17, 2026